🇺🇸 Pyrrolidine in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 5
Most-reported reactions
- Blood Potassium Decreased — 1 report (20%)
- Haematuria — 1 report (20%)
- Protein Total Decreased — 1 report (20%)
- Stevens-Johnson Syndrome — 1 report (20%)
- White Blood Cells Urine Positive — 1 report (20%)
Other Other approved in United States
Frequently asked questions
Is Pyrrolidine approved in United States?
Pyrrolidine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Pyrrolidine in United States?
Xijing Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.